https://ascopubs.org/doi/10.1200/JCO.20 ... 3?hl=en-US
Per the ASCO/EHA presentation
Considerable improvements in BAT post Rux discontinuation. Not only helps explain delays, stock tank and what interim may show. Waiting to see what post EHA KOLs (especially Dr. Mascarenhas) might have to say but this information is considerably different than the working mOS of 15-18 months that has been quoted in many articles and presentations by Gern and some KOLs to date.
Evolving BAT data
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
-
Secret Third Arm
- Posts: 64
- Joined: Tue Aug 28, 2018 3:26 pm
Re: Evolving BAT data
Hi BP, how does this differ from the ongoing conversations that we have been having? This information has been out for weeks and pretty thoroughly discussed here and elsewhere I thought. Am I missing something?
-
biopearl123
- Posts: 2591
- Joined: Fri Jul 20, 2018 5:13 pm
Re: Evolving BAT data
Just documenting the actual JCO print copy. Easier to read than the poster.